Evidence map›Paper›PMID 33543033›Full record

ArticleMatrix biology plus2020

Calreticulin is important for the development of renal fibrosis and dysfunction in diabetic nephropathy.

Ailing Lu, Manuel A Pallero, Benjamin Y Owusu, Anton V Borovjagin, Weiqi Lei, Paul W Sanders, Joanne E Murphy-Ullrich

Open access · goldAbstract read
In one paragraph

Article in Matrix biology plus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Calreticulin in renal fibrosis: A short review.Journal of cellular and molecular medicine · 2022
    Review
  11. Article
  12. miRNA-486-5p: signaling targets and role in non-malignant disease.Cellular and molecular life sciences : CMLS · 2022
    Review
  13. Article
  14. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Roles of SIRT6 in kidney disease: a novel therapeutic target.Cellular and molecular life sciences : CMLS · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ailing LuDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
Manuel A PalleroDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
Benjamin Y OwusuDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
Anton V BorovjaginDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
Weiqi LeiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
Paul W SandersDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.
Joanne E Murphy-UllrichDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL35294-0019, USA.
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB-UCSD O'Brien Center for Acute Kidney Injury ResearchU54DK137307 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PAUL W. SANDERS · 2023 to 2026
$4.4M
BLRD VA I01 BX005640NCI NIH HHS P30 CA013148NIAMS NIH HHS P30 AR048311NIDDK NIH HHS P30 DK079337NIDDK NIH HHS U54 DK137307
6 · The paper itself

Abstract

Previously, our lab showed that the endoplasmic reticulum (ER) and calcium regulatory protein, calreticulin (CRT), is important for collagen transcription, secretion, and assembly into the extracellular matrix (ECM) and that ER CRT is critical for TGF-β stimulation of type I collagen transcription through stimulation of ER calcium release and NFAT activation. Diabetes is the leading cause of end stage renal disease. TGF-β is a key factor in the pathogenesis of diabetic nephropathy. However, the role of calreticulin (

Indexed as

4-PBA, 4-phenylbutyrateCalreticulinCollagenCRT, calreticulinDiabetic nephropathyECM, extracellular matrixEMT, epithelial to mesenchymal transitionER, endoplasmic reticulumFibrosisGRP78, glucose related protein 78MB/US, microbubble/ultrasoundNFATNFAT, nuclear factor of activated T cellsPAS, Periodic Acid-SchiffSTZ, streptozotocinTGF-β, transforming growth factor-βUPR, unfolded protein response

Identifiers

PMID33543033
PMCPMC7852315
OpenAlexW3014256861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.